B. Riley upgraded Vaxart to Buy from Neutral with a $2 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VXRT:
- Biotech Alert: Searches spiking for these stocks today
- Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
- Vaxart receives $9.27M BARDA project award for Phase 2B trial on oral pill
- Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
- Vaxart CEO Andrei Floroiu resigns, Michael Finney named interim